The Lancet. Oncology

1-16 of 16
 
Check/Uncheck all
  • 2022 | Journal Article
    ​ ​Stereotactic radiosurgery for patients with small-cell lung cancer brain metastases​
    Rieken, S.​ (2022) 
    The Lancet Oncology, 23(7) pp. 832​-833​.​ DOI: https://doi.org/10.1016/S1470-2045(22)00301-1 
    ​Details  DOI 
  • 2022 | Journal Article | Research Paper | 
    ​ ​Immunogenicity of COVID-19 vaccination in melanoma patients under immune checkpoint blockade​
    Niewolik, J.; Mikuteit, M.; Cossmann, A.; Vahldiek, K.; Gutzmer, R.; Müller, F.   & Schröder, D.  et al.​ (2022) 
    Oncology,.​ DOI: https://doi.org/10.1159/000524894 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study​
    Glasbey, J.; Ademuyiwa, A.; Adisa, A.; AlAmeer, E.; Arnaud, A. P; Ayasra, F. & Azevedo, J. et al.​ (2021) 
    The Lancet Oncology, 22(11) pp. 1507​-1517​.​ DOI: https://doi.org/10.1016/S1470-2045(21)00493-9 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials​
    Doebele, R. C; Drilon, A.; Paz-Ares, L.; Siena, S.; Shaw, A. T; Farago, A. F & Blakely, C. M et al.​ (2020) 
    The Lancet Oncology, 21(2) pp. 271​-282​.​ DOI: https://doi.org/10.1016/S1470-2045(19)30691-6 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Biological material collection to advance translational research and treatment of children with CNS tumours: position paper from the SIOPE Brain Tumour Group​
    Rutkowski, S.; Modena, P.; Williamson, D.; Kerl, K.; Nysom, K.; Pizer, B. & Bartels, U. et al.​ (2018) 
    The Lancet Oncology, 19(8) pp. e419​-e428​.​ DOI: https://doi.org/10.1016/S1470-2045(18)30364-4 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Integration of oncology and palliative care: a Lancet Oncology Commission​
    Kaasa, S.; Loge, J. H; Aapro, M.; Albreht, T.; Anderson, R.; Bruera, E. & Brunelli, C. et al.​ (2018) 
    The Lancet Oncology, 19(11) pp. e588​-e653​.​ DOI: https://doi.org/10.1016/S1470-2045(18)30415-7 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial​
    Trněný, M.; Lamy, T.; Walewski, J.; Belada, D.; Mayer, J.; Radford, J. & Jurczak, W. et al.​ (2016) 
    The Lancet Oncology, 17(3) pp. 319​-331​.​ DOI: https://doi.org/10.1016/S1470-2045(15)00559-8 
    ​Details  DOI  PMID  PMC  WoS 
  • 2014 | Journal Article
    ​ ​Rituximab after lymphoma-directed conditioning and allogeneic stem-cell transplantation for relapsed and refractory aggressive non-Hodgkin lymphoma (DSHNHL R3): an open-label, randomised, phase 2 trial​
    Glass, B.; Hasenkamp, J.; Wulf, G.; Dreger, P.; Pfreundschuh, M.; Gramatzki, M. & Silling, G. et al.​ (2014) 
    The Lancet Oncology, 15(7) pp. 757​-766​.​ DOI: https://doi.org/10.1016/S1470-2045(14)70161-5 
    ​Details  DOI 
  • 2012 | Journal Article
    ​ ​Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1)​
    Schmitz, N.; Nickelsen, M.; Ziepert, M.; Haenel, M.; Borchmann, P.; Schmidt, C. D. & Viardot, A. et al.​ (2012) 
    The Lancet Oncology, 13(12) pp. 1250​-1259​.​ DOI: https://doi.org/10.1016/S1470-2045(12)70481-3 
    ​Details  DOI  PMID  PMC  WoS 
  • 2011 | Journal Article
    ​ ​CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group​
    Pfreundschuh, M.; Kuhnt, E.; Truemper, L. H.; Osterborg, A.; Trneny, M.; Shepherd, L. & Gill, D. S. et al.​ (2011) 
    The Lancet Oncology, 12(11) pp. 1013​-1022​.​ DOI: https://doi.org/10.1016/S1470-2045(11)70235-2 
    ​Details  DOI  PMID  PMC  WoS 
  • 2010 | Journal Article
    ​ ​Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial​
    Folprecht, G.; Gruenberger, T.; Bechstein, W. O.; Raab, H.-R.; Lordick, F.; Hartmann, J. T. & Lang, H. et al.​ (2010) 
    The Lancet Oncology, 11(1) pp. 38​-47​.​
    ​Details  PMID  PMC  WoS 
  • 2010 | Journal Article | Letter Note
    ​ ​GPC5 rs2352028 variant and risk of lung cancer in never smokers​
    Landi, M. T.; Chatterjee, N.; Caporaso, N. E.; Rotunno, M.; Albanes, D.; Thun, M. & Wheeler, W. et al.​ (2010) 
    The Lancet Oncology, 11(8) pp. 714​-716​.​ DOI: https://doi.org/10.1016/S1470-2045(10)70096-6 
    ​Details  DOI  PMID  PMC  WoS 
  • 2008 | Review | 
    ​ ​Crises in palliative care-a comprehensive approach​
    Nauck, F.  & Alt-Epping, B.​ (2008)
    The Lancet Oncology, 9​(11) pp. 1086​-1091​.​
    Lancet Ltd. DOI: https://doi.org/10.1016/S1470-2045(08)70278-X 
    ​Details  DOI  PMID  PMC  WoS 
  • 2008 | Journal Article
    ​ ​Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)​
    Pfreundschuh, M.; Schubert, J.; Ziepert, M.; Schmits, R.; Mohren, M.; Lengfelder, E. & Reiser, M. et al.​ (2008) 
    The Lancet Oncology, 9(2) pp. 105​-116​.​ DOI: https://doi.org/10.1016/S1470-2045(08)70002-0 
    ​Details  DOI  PMID  PMC  WoS 
  • 2006 | Journal Article
    ​ ​CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group​
    Pfreundschuh, M.; Truemper, L. H.; Osterborg, A.; Pettengell, R.; Trneny, M.; Imrie, K. & Ma, D. et al.​ (2006) 
    The Lancet Oncology, 7(5) pp. 379​-391​.​ DOI: https://doi.org/10.1016/S1470-2045(06)70664-7 
    ​Details  DOI  PMID  PMC  WoS 
  • 2005 | Journal Article
    ​ ​Antiemetic guidelines: are they being used?​
    Kaiser, R.​ (2005) 
    The Lancet Oncology, 6(8) pp. 622​-625​.​ DOI: https://doi.org/10.1016/S1470-2045(05)70284-9 
    ​Details  DOI  PMID  PMC  WoS 

Type

Subtype

Date issued

Publication Affiliation

Fulltext

Options

Citation Style

GRO View APA Chicago MLA Vancouver

Sort

Issue Date
ASC DESC
Title
ASC DESC

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.